Franc Del Fosse
2017
In 2017, Franc Del Fosse earned a total compensation of $1.3M as General Counsel & Corporate Secretary at INSYS Therapeutics, a 96% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,200 |
|---|---|
| Option Awards | $517,425 |
| Salary | $325,000 |
| Stock Awards | $268,780 |
| Other | $8,939 |
| Total | $1,307,344 |
Del Fosse received $517.4K in option awards, accounting for 40% of the total pay in 2017.
Del Fosse also received $187.2K in non-equity incentive plan, $325K in salary, $268.8K in stock awards and $8.9K in other compensation.
Rankings
In 2017, Franc Del Fosse's compensation ranked 7,695th out of 14,666 executives tracked by ExecPay. In other words, Del Fosse earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,695 out of 14,666 | 48th |
Division Manufacturing | 2,878 out of 5,772 | 50th |
Major group Chemicals And Allied Products | 935 out of 2,075 | 55th |
Industry group Drugs | 723 out of 1,731 | 58th |
Industry Pharmaceutical Preparations | 563 out of 1,333 | 58th |
Source: SEC filing on April 16, 2018.
Del Fosse's colleagues
We found five more compensation records of executives who worked with Franc Del Fosse at INSYS Therapeutics in 2017.
2017
Saeed Motahari
INSYS Therapeutics
Chief Executive Officer
2017
Andrew Long
INSYS Therapeutics
Chief Financial Officer
2017
Darryl Baker
INSYS Therapeutics
Chief Financial Officer
2017
Santosh Vetticaden
INSYS Therapeutics
Chief Executive Officer
2017
John Kapoor
INSYS Therapeutics